Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

PHRI Population Health Research Institute International

237 Barton Street East, L8L 2X2

About the sponsor

Clinical activity is centered on atrial fibrillation in patients at elevated thromboembolic risk, with attention to treatment decisions in those with prior intracranial hemorrhage.

  • Atrial fibrillation
  • Stroke prevention
  • Systemic embolism

The research focus includes balancing anticoagulant therapy against non-antithrombotic approaches in a high-risk cardiac population.

About Specializations

PHRI Population Health Research Institute International runs clinical trials in conditions such as Haemorrhage intracranial, Disease risk factor, Atrial fibrillation, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Disease risk factor+1

Not yet recruiting

Colchicine for Reducing Dependency and Vascular Events in Patients After Acute Intracerebral Hemorrhage

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Hamilton Health Sciences Corporation

Atrial fibrillation+1

Not recruiting

Study on Edoxaban for Patients with Atrial Fibrillation and Previous Brain Bleeding

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Edoxaban
  • Sponsor:Hamilton Health Sciences Corporation

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.